The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection ; volume:24 ; number:1 ; day:13 ; month:3 ; year:2023 ; pages:1-23 ; date:12.2023
Genome biology ; 24, Heft 1 (13.3.2023), 1-23, 12.2023
- Urheber
-
Goldswain, Hannah
Dong, Xiaofeng
Penrice-Randal, Rebekah
Alruwaili, Muhannad
Shawli, Ghada T.
Prince, Tessa
Williamson, Maia Kavanagh
Raghwani, Jayna
Randle, Nadine
Jones, Benjamin
Donovan-Banfield, I’ah
Salguero, Francisco J.
Tree, Julia A.
Hall, Yper
Hartley, Catherine
Erdmann, Maximilian
Bazire, James
Jearanaiwitayakul, Tuksin
Semple, Malcolm G.
Openshaw, Peter J. M.
Baillie, J. Kenneth
Emmett, Stevan R.
Digard, Paul
Matthews, David A.
Turtle, Lance
Darby, Alistair C.
Davidson, Andrew D.
Carroll, Miles W.
Hiscox, Julian A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13059-023-02881-5
- URN
-
urn:nbn:de:101:1-2408120906245.700335034820
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goldswain, Hannah
- Dong, Xiaofeng
- Penrice-Randal, Rebekah
- Alruwaili, Muhannad
- Shawli, Ghada T.
- Prince, Tessa
- Williamson, Maia Kavanagh
- Raghwani, Jayna
- Randle, Nadine
- Jones, Benjamin
- Donovan-Banfield, I’ah
- Salguero, Francisco J.
- Tree, Julia A.
- Hall, Yper
- Hartley, Catherine
- Erdmann, Maximilian
- Bazire, James
- Jearanaiwitayakul, Tuksin
- Semple, Malcolm G.
- Openshaw, Peter J. M.
- Baillie, J. Kenneth
- Emmett, Stevan R.
- Digard, Paul
- Matthews, David A.
- Turtle, Lance
- Darby, Alistair C.
- Davidson, Andrew D.
- Carroll, Miles W.
- Hiscox, Julian A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Loss of T‐bet confers survival advantage to influenza–bacterial superinfection
A novel PBP3 substitution in Haemophilus influenzae confers reduced aminopenicillin susceptibility
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic
Substitution and Complementarity under Comparative Advantage and the Accumulation of Human Capital
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Schnellnachweis von SARS-CoV-2 mit recombinase polymerase amplification
Fourth NF-κB site in HIV-1 subtype-C LTR confers functional advantage to viral gene expression
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
SARS-CoV-2 RNA polymerase as target for antiviral therapy
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme
Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
Loss of T‐bet confers survival advantage to influenza–bacterial superinfection
A novel PBP3 substitution in Haemophilus influenzae confers reduced aminopenicillin susceptibility
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic
Substitution and Complementarity under Comparative Advantage and the Accumulation of Human Capital
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Schnellnachweis von SARS-CoV-2 mit recombinase polymerase amplification
Fourth NF-κB site in HIV-1 subtype-C LTR confers functional advantage to viral gene expression
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
SARS-CoV-2 RNA polymerase as target for antiviral therapy
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme
Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
Loss of T‐bet confers survival advantage to influenza–bacterial superinfection
A novel PBP3 substitution in Haemophilus influenzae confers reduced aminopenicillin susceptibility
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic
Substitution and Complementarity under Comparative Advantage and the Accumulation of Human Capital
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Schnellnachweis von SARS-CoV-2 mit recombinase polymerase amplification
Fourth NF-κB site in HIV-1 subtype-C LTR confers functional advantage to viral gene expression
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
SARS-CoV-2 RNA polymerase as target for antiviral therapy
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme